CUMBERLAND PHARMACEUTICALS INC Insider Trading for March 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CUMBERLAND PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CUMBERLAND PHARMACEUTICALS INC for March 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Krogulski Kenneth | Director | Grant | A | 6.70 | 1,000 | 6,700 | 155,300 | 154.3 K to 155.3 K (+0.65 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Payment of Exercise | F | 6.70 | 890 | 5,963 | 144,667 | 145.6 K to 144.7 K (-0.61 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Payment of Exercise | F | 6.70 | 890 | 5,963 | 144,667 | 145.6 K to 144.7 K (-0.61 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Grant | A | 6.70 | 5,000 | 33,500 | 145,557 | 140.6 K to 145.6 K (+3.56 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Grant | A | 6.70 | 5,000 | 33,500 | 145,557 | 140.6 K to 145.6 K (+3.56 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Payment of Exercise | F | 6.70 | 2,557 | 17,132 | 130,304 | 132.9 K to 130.3 K (-1.92 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Payment of Exercise | F | 6.70 | 2,557 | 17,132 | 130,304 | 132.9 K to 130.3 K (-1.92 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Grant | A | 6.70 | 25,000 | 167,500 | 132,861 | 107.9 K to 132.9 K (+23.18 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Pavliv Leo | SVP and Chief Devel ... | Grant | A | 6.70 | 25,000 | 167,500 | 132,861 | 107.9 K to 132.9 K (+23.18 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Herman James L | VP and Chief Compli ... | Payment of Exercise | F | 6.70 | 2,999 | 20,093 | 42,949 | 45.9 K to 42.9 K (-6.53 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Herman James L | VP and Chief Compli ... | Payment of Exercise | F | 6.70 | 2,999 | 20,093 | 42,949 | 45.9 K to 42.9 K (-6.53 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Herman James L | VP and Chief Compli ... | Grant | A | 6.70 | 3,000 | 20,100 | 45,948 | 42.9 K to 45.9 K (+6.99 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Herman James L | VP and Chief Compli ... | Grant | A | 6.70 | 3,000 | 20,100 | 45,948 | 42.9 K to 45.9 K (+6.99 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | KAZIMI A J | Chairman and CEO | Payment of Exercise | F | 6.70 | 24,373 | 163,299 | 5,905,897 | 5.9 M to 5.9 M (-0.41 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | KAZIMI A J | Chairman and CEO | Payment of Exercise | F | 6.70 | 24,373 | 163,299 | 5,905,897 | 5.9 M to 5.9 M (-0.41 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | KAZIMI A J | Chairman and CEO | Grant | A | 6.70 | 100,000 | 670,000 | 5,930,270 | 5.8 M to 5.9 M (+1.72 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | KAZIMI A J | Chairman and CEO | Grant | A | 6.70 | 100,000 | 670,000 | 5,930,270 | 5.8 M to 5.9 M (+1.72 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Bernard Gordon R | Director | Grant | A | 6.70 | 1,000 | 6,700 | 118,729 | 117.7 K to 118.7 K (+0.85 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Bernard Gordon R | Director | Grant | A | 6.70 | 1,000 | 6,700 | 118,729 | 117.7 K to 118.7 K (+0.85 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Griggs Jonathan | Director | Grant | A | 6.70 | 1,000 | 6,700 | 11,803 | 10.8 K to 11.8 K (+9.26 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Griggs Jonathan | Director | Grant | A | 6.70 | 1,000 | 6,700 | 11,803 | 10.8 K to 11.8 K (+9.26 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Jones James | Director | Grant | A | 6.70 | 1,000 | 6,700 | 11,700 | 10.7 K to 11.7 K (+9.35 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Jones James | Director | Grant | A | 6.70 | 1,000 | 6,700 | 11,700 | 10.7 K to 11.7 K (+9.35 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Young Caroline | Director | Grant | A | 6.70 | 1,000 | 6,700 | 3,000 | 2 K to 3 K (+50.00 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Young Caroline | Director | Grant | A | 6.70 | 1,000 | 6,700 | 3,000 | 2 K to 3 K (+50.00 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | JACOBS JOEY A | Director | Grant | A | 6.70 | 5,000 | 33,500 | 66,000 | 61 K to 66 K (+8.20 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | JACOBS JOEY A | Director | Grant | A | 6.70 | 5,000 | 33,500 | 66,000 | 61 K to 66 K (+8.20 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Bonner Michael | Chief Financial Off ... | Payment of Exercise | F | 6.70 | 843 | 5,648 | 17,654 | 18.5 K to 17.7 K (-4.56 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Bonner Michael | Chief Financial Off ... | Grant | A | 6.70 | 2,500 | 16,750 | 18,497 | 16 K to 18.5 K (+15.63 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Bonner Michael | Chief Financial Off ... | Payment of Exercise | F | 6.70 | 843 | 5,648 | 17,654 | 18.5 K to 17.7 K (-4.56 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Bonner Michael | Chief Financial Off ... | Buy | P | 6.72 | 300 | 2,016 | 15,997 | 15.7 K to 16 K (+1.91 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Bonner Michael | Chief Financial Off ... | Grant | A | 6.70 | 2,500 | 16,750 | 18,497 | 16 K to 18.5 K (+15.63 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Bonner Michael | Chief Financial Off ... | Buy | P | 6.72 | 300 | 2,016 | 15,997 | 15.7 K to 16 K (+1.91 %) |